Bak Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61174r-TR |
| Product Name | Bak Recombinant Antibody |
| Applications |
WB
FCM
IHC-P
IHC-F
IF(IHC-P)
IF(ICC)
IP
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human BAK1 |
| Clonality | Recombinant |
| Clone # | 5C2 |
| Isotype | IgG |
| Concentration | 1mg/ml |
| Purification | purified by Protein A. |
| Storage Buffer | 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 578 |
| Swiss Prot | Q16611 |
| Subcellular location | Cytoplasm, Cell membrane |
| Synonyms | BAK; BAK-LIKE; BCL2L7; CDN1; N-BAK1; N-Bak; BAK_HUMAN; BAK1; Apoptosis regulator BAK; Bcl-2-like protein 7 (Bcl2-L-7); BAK_MOUSE; BCL2 antagonist/killer 1; BCL2-antagonist/killer 1 |
| Background | In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti-apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis. |
| Application Dilution | |
| WB | 1:500-2000 |
| FCM | FCM1ug/Test |
| IHC-P | IHC-P1:200-500 |
| IHC-F | IHC-F1:200-500 |
| IF(IHC-P) | IFIHC-P1:200-500 |
| IF(ICC) | IFICC1:100-500 |
| IP | IP1:20-50 |